«‹12345»Seite
5 Artikel mit Literatur, Seite 1 von 5

MEDIZIN: Klinische Leitlinie

Infarktbedingter kardiogener Schock – Diagnostik, Monitoring und Therapie

Cardiogenic Shock Due to Myocardial Infarction: Diagnosis, Monitoring and Treatment: A German-Austrian S3 Guideline
Dtsch Arztebl Int 2012; 109(19): 343-51; DOI: 10.3238/arztebl.2012.0343

Werdan, Karl; Ruß, Martin; Buerke, Michael; Delle-Karth, Georg; Geppert, Alexander; Schöndube, Friedrich A.

1. Nabel EG, Braunwald E: A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012; 366: 54–63. CrossRef MEDLINE
2.Hochman JS, Sleeper LA, Webb JG, et al.: Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295: 2511–5. CrossRef MEDLINE PubMed Central
3.Hochman JS, Sleeper LA, Webb JG, et al.: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999; 341: 625–34. CrossRef MEDLINE
4.Kohsaka S, Menon V, Lowe AM, et al.: Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 2005; 165: 1643–50. CrossRef MEDLINE
5.Van de Werf F, Bax J, Betriu A, et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008; 29: 2909–45. CrossRef MEDLINE
6.Werdan K, Ruß M, Buerke M, et al.: Deutsch-österreichische S3-Leitlinie Infarktbedingter kardiogener Schock. Diagnose, Monitoring und Therapie. Der Kardiologe 2011; 5: 166–224; Intensivmed 2011; 48: 291–344; Intensiv- und Notfallbehandlung 2011; 36: 49–130.
7.Hochman JS, Sleeper LA, White HD, et al.: One-year survival following early revascularization for cardiogenic shock. Jama 2001; 285: 190–2. CrossRef MEDLINE
8.Arntz HR, Bossaert LL, Danchin N, Nikolaou NI: European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes. Resuscitation 2010; 81: 1353–63. CrossRef MEDLINE
9.Nolan JP, Soar J: Postresuscitation care: entering a new era. Curr Opin Crit Care 2010; 16: 216–22. CrossRef MEDLINE
10.Cotter G, Moshkovitz Y, Kaluski E et al.: The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. European Journal of Heart Failure 2003; 5: 443–51. CrossRef MEDLINE
11.Fincke R, Hochman JS, Lowe AM et al.: Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry. Journal of the American College of Cardiology 2004; 44: 340–8. CrossRef MEDLINE
12.Mendoza DD, Cooper HA, Panza JA: Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 2007; 153: 366–70. CrossRef MEDLINE
13.Russ MA, Prondzinsky R, Carter JM, et al.: Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan. Crit Care Med 2009; 37: 3017–23. CrossRef MEDLINE
14.De Backer D, Biston P, Devriendt J, et al.: Comparison of Dopamine and Norepinephrine in the treatment of shock. N Engl J Med 2010; 362: 779–89. CrossRef MEDLINE
15.Sakr Y, Reinhart K, Vincent JL, et al.: Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006; 34: 589–97. CrossRef MEDLINE
16.Fuhrmann JT, Schmeisser A, Schulze MR, et al.: Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med 2008; 36: 2257–66. CrossRef MEDLINE
17.Metra M, Nodari S, D’Aloia A, et al. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. Journal of the American College of Cardiology 2002; 40: 1248–58. CrossRef MEDLINE
18.Prondzinsky R, Lemm H, Swyter M, et al.: Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 152–60. CrossRef MEDLINE
19.Unverzagt S, Machemer MT, Solms A, et al.: Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev 2011; CD007398. MEDLINE
20.Sjauw KD, Engstrom AE, Vis MM, et al.: A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009; 30: 459–68. CrossRef MEDLINE
21.Cyrus T, Mathews SJ, Lasala JM: Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock. Catheter Cardiovasc Interv 2010; 75(Suppl 1): 1–6. CrossRef MEDLINE
22.Kouraki K, Schneider S, Uebis R, et al.: Characteristics and clinical outcome of 458 patients with acute myocardial infarction requiring mechanical ventilation. Results of the BEAT registry of the ALKK-study group. Clin Res Cardiol 2011; 100: 235–9. CrossRef MEDLINE
23.Finfer S, Chittock DR, Su SY, et al.: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283–97. CrossRef MEDLINE
24.Cobb LA, Killip T, Lambrew CT, et al.: Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. Jama 2005; 293: 2597; Letters and authors' reply: 2005; 293: 2596–7. MEDLINE
25.The Triumph-Investigators: Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. Jama 2007; 297: 1657–66. CrossRef MEDLINE
26.Thiele H, Schuler G, Neumann FJ, et al. on behalf of the IABP-Shock II Trial Investigators: Intraaortic balloon counterpulsation in myocardial infarction complicated by cardiogenic shock: Design and rational of the intraaortic balloon pump in cardiogenic shock II trial (IABP-SHOCK II). Am Heart J, 2012, in press.
«‹12345»Seite
5 Artikel mit Literatur, Seite 1 von 5

Login

E-Mail

Passwort


Passwort vergessen?

Registrieren

Eingeloggt als

Suchen in